|
WO2019018898A1
|
|
Cell penetrating peptides and related compositions and methods
|
|
WO2017070742A1
|
|
Use of spycatcher as a protein scaffold for peptide display; and spycatcher/spytag cyclised peptides displayed on bacteriophage
|
|
CA2916102A1
|
|
Method of monitoring cellular trafficking of peptides
|
|
EP2812349A1
|
|
Methods for the characterisation of interaction sites on target proteins
|
|
EP2714971A1
|
|
Method of determining, identifying or isolating cell-penetrating peptides
|
|
AU2011301788A1
|
|
Peptide inhibitors of CD40L signaling and uses therefor
|
|
CA2730316A1
|
|
Peptide inhibitors of cd40l signaling and uses therefor
|
|
EP2170932A1
|
|
Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith
|
|
CA2950465A1
|
|
Method of constructing and screening libraries of peptide structures
|
|
WO2008034161A1
|
|
Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor
|
|
CA2577995A1
|
|
Peptide inhibitors of c-jun dimerization and uses thereof
|
|
AU2005250511A1
|
|
Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
|
|
WO2004106543A1
|
|
An improved genetic screen for interaction interface mapping
|
|
AU2004213477A1
|
|
Modulating screening thresholds for N-hybrid screening
|
|
US2007031832A1
|
|
Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
|
|
US7270969B2
|
|
Methods of constructing and screening diverse expression libraries
|
|
AU2003900786A0
|
|
Methods of regulating gene expression
|
|
EP1268842A1
|
|
Improved reverse n-hybrid screening method
|
|
AU2001245584B2
|
|
Improved reverse n-hybrid screening method
|
